Your browser doesn't support javascript.
loading
Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases.
Alenezi, Wejdan M; Fierheller, Caitlin T; Serruya, Corinne; Revil, Timothée; Oros, Kathleen K; Subramanian, Deepak N; Bruce, Jeffrey; Spiegelman, Dan; Pugh, Trevor; Campbell, Ian G; Mes-Masson, Anne-Marie; Provencher, Diane; Foulkes, William D; Haffaf, Zaki El; Rouleau, Guy; Bouchard, Luigi; Greenwood, Celia M T; Ragoussis, Jiannis; Tonin, Patricia N.
Affiliation
  • Alenezi WM; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Fierheller CT; Cancer Research Program, Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, QC, Canada.
  • Serruya C; Department of Medical Laboratory Technology, Taibah University, Medina, Saudi Arabia.
  • Revil T; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Oros KK; Cancer Research Program, Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, QC, Canada.
  • Subramanian DN; Cancer Research Program, Centre for Translational Biology, The Research Institute of McGill University Health Centre, Montreal, QC, Canada.
  • Bruce J; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Spiegelman D; McGill Genome Centre, McGill University, Montreal, QC, Canada.
  • Pugh T; Lady Davis Institute for Medical Research of the Jewish General Hospital, Montreal, QC, Canada.
  • Campbell IG; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Mes-Masson AM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Provencher D; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Foulkes WD; Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
  • Haffaf ZE; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Rouleau G; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Bouchard L; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Greenwood CMT; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ragoussis J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Tonin PN; Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, QC, Canada.
Front Oncol ; 13: 1111191, 2023.
Article in En | MEDLINE | ID: mdl-36969007
ABSTRACT
Not all familial ovarian cancer (OC) cases are explained by pathogenic germline variants in known risk genes. A candidate gene approach involving DNA repair pathway genes was applied to identify rare recurring pathogenic variants in familial OC cases not associated with known OC risk genes from a population exhibiting genetic drift. Whole exome sequencing (WES) data of 15 OC cases from 13 families tested negative for pathogenic variants in known OC risk genes were investigated for candidate variants in 468 DNA repair pathway genes. Filtering and prioritization criteria were applied to WES data to select top candidates for further analyses. Candidates were genotyped in ancestry defined study groups of 214 familial and 998 sporadic OC or breast cancer (BC) cases and 1025 population-matched controls and screened for additional carriers in 605 population-matched OC cases. The candidate genes were also analyzed in WES data from 937 familial or sporadic OC cases of diverse ancestries. Top candidate variants in ERCC5, EXO1, FANCC, NEIL1 and NTHL1 were identified in 5/13 (39%) OC families. Collectively, candidate variants were identified in 7/435 (1.6%) sporadic OC cases and 1/566 (0.2%) sporadic BC cases versus 1/1025 (0.1%) controls. Additional carriers were identified in 6/605 (0.9%) OC cases. Tumour DNA from ERCC5, NEIL1 and NTHL1 variant carriers exhibited loss of the wild-type allele. Carriers of various candidate variants in these genes were identified in 31/937 (3.3%) OC cases of diverse ancestries versus 0-0.004% in cancer-free controls. The strategy of applying a candidate gene approach in a population exhibiting genetic drift identified new candidate OC predisposition variants in DNA repair pathway genes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country:
...